At 86, Professor Ruth Arnon is going strong. Exhilarated to wake every morning to hit the laboratory, this world-renowned biochemist from Weizmann Institute of Science is the co-creator of multiple sclerosis drug Copaxone.
Professor Arnon was born in Tel Aviv in 1933 and has pursued medical cures advancing chemical methods to immunology. Presently on the board of Israel-based BiondVax Pharmaceuticals, a Jerusalem-based firm developing an unprecedented, universal influenza vaccine based on many years of research from the Weismann Institute reports the Jerusalem Post.
Arnon became the first female president Israel Academy of Sciences and the Humanities.
Excited about Research
Professor Arnon recently told the Jerusalem Post, “There is nothing more exciting than planning an experiment and getting the results” and continued, “If you get the results you wanted, it’s extremely exciting. If you didn’t expect the results, it can sometimes be even more exciting.”
Professor Arnon was intensively involved with the research and development associated with Copaxone while at Weizmann Institute. The drug was commercialized by Israeli powerhouse Teva—the drug was...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).